pharmaceutical-development Downloads
7 downloads found
HDX has become an indispensable tool for protein binding studies in pharmaceutical development. LEAP Technologies has been automating HDX experiments for over 15 years, and is the industry leader in the field. Our HDX systems are helping researchers across the globe come to answers about their proteins faster than traditional ...
Microbiologists are no strangers to the fact that safety and effectiveness are crucial elements of developing pharmaceutical and personal care products. We created our EZ-PEC™ quantitative microorganisms to help laboratories conduct Antimicrobial Effectiveness and Preservative Efficacy testing with convenience and confidence. Following a few simple steps, EZ-PEC™ delivers a final ...
Diabetes has developed into one of the most serious health threats to the public throughout the world. A number of factors are reported to be associated with the exacerbation of diabetes. Creative Enzymes is devoted to supporting diabetes research and drug development in pharmaceuticals and institutes with our enzyme products. https://diagnostic-enzymes.creative-enzymes.com/diabetes.html ...
This three-day course is designed to provide a basic understanding of the significant process development effort involved in taking an R&D laboratory formulation to commercial production. This course will focus on two main ...
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic Remygen. Diamyd and Remygen are evaluated in ongoing clinical studies. The therapies target the underlying causes of diabetes, dysfunction and loss of ...
With the EU In Vitro Diagnostic Medical Devices Regulation (IVDR) becoming applicable in May 2022, the European Bioanalysis Forum, as many others, is looking at the impact of this regulation on (bio)pharmaceutical drug research and development. Already, we observe a growing concern of the industry on potential scope creep of the IVDR into early clinical studies for assets where it is believed the ...
Frank MoffattDR. FRAnk MoFFAtt — business development ManagerSince July 2010 Business Development Manager at Solvias AG. ...